Total Current Liabilities - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

NuVasive Inc
Total Current Liabilities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Total Current Liabilities
$582.6m
CAGR 3-Years
-10%
CAGR 5-Years
23%
CAGR 10-Years
19%
Becton Dickinson and Co
NYSE:BDX
Total Current Liabilities
$6.6B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
12%
Boston Scientific Corp
NYSE:BSX
Total Current Liabilities
$5.6B
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Current Liabilities
$6.9B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Total Current Liabilities
$13.8B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
3%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Liabilities
$1.5B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is NuVasive Inc's Total Current Liabilities?
Total Current Liabilities
582.6m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Total Current Liabilities amounts to 582.6m USD.

What is NuVasive Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
19%

Over the last year, the Total Current Liabilities growth was -17%. The average annual Total Current Liabilities growth rates for NuVasive Inc have been -10% over the past three years , 23% over the past five years , and 19% over the past ten years .

Back to Top